These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Guidelines for the diagnosis and management of familial long QT syndrome. Skinner JR; Heart Lung Circ; 2007 Feb; 16(1):22-4. PubMed ID: 17194624 [No Abstract] [Full Text] [Related]
26. Sodium channel block by ranolazine in an experimental model of stretch-related atrial fibrillation: prolongation of interatrial conduction time and increase in post-repolarization refractoriness. Milberg P; Frommeyer G; Ghezelbash S; Rajamani S; Osada N; Razvan R; Belardinelli L; Breithardt G; Eckardt L Europace; 2013 May; 15(5):761-9. PubMed ID: 23376977 [TBL] [Abstract][Full Text] [Related]
27. Long QT syndrome in pregnancy: A successful case of ICD implantation during the prenatal period. Yano M; Nishida Y; Kai K; Ishii T; Takahashi N; Narahara H J Obstet Gynaecol; 2017 May; 37(4):531-532. PubMed ID: 28287284 [No Abstract] [Full Text] [Related]
28. Ranolazine: new drug. Stable angina: not worth the risk. Prescrire Int; 2009 Aug; 18(102):148-7. PubMed ID: 19743543 [TBL] [Abstract][Full Text] [Related]
29. Ranolazine: an antianginal drug with antiarrhythmic properties. Tamargo J; Caballero R; Delpón E Expert Rev Cardiovasc Ther; 2011 Jul; 9(7):815-27. PubMed ID: 21809962 [TBL] [Abstract][Full Text] [Related]
30. The risk of sudden cardiac death in patients with non-ST elevation acute coronary syndrome and prolonged QTc interval: effect of ranolazine. Karwatowska-Prokopczuk E; Wang W; Cheng ML; Zeng D; Schwartz PJ; Belardinelli L Europace; 2013 Mar; 15(3):429-36. PubMed ID: 23258816 [TBL] [Abstract][Full Text] [Related]
31. Additional gene variants reduce effectiveness of beta-blockers in the LQT1 form of long QT syndrome. Kobori A; Sarai N; Shimizu W; Nakamura Y; Murakami Y; Makiyama T; Ohno S; Takenaka K; Ninomiya T; Fujiwara Y; Matsuoka S; Takano M; Noma A; Kita T; Horie M J Cardiovasc Electrophysiol; 2004 Feb; 15(2):190-9. PubMed ID: 15028050 [TBL] [Abstract][Full Text] [Related]
32. Macrovolt T-wave alternans in an asymptomatic woman with long-QT syndrome: a rare but clinically significant finding. Bennett MT; Sy RW; Chattha I; Krahn AD J Cardiovasc Electrophysiol; 2010 Jul; 21(7):825. PubMed ID: 20132384 [No Abstract] [Full Text] [Related]
33. A high-risk patient with long-QT syndrome with no response to cardioselective beta-blockers. Toyota N; Miyazaki A; Sakaguchi H; Shimizu W; Ohuchi H Heart Vessels; 2015 Sep; 30(5):687-91. PubMed ID: 25028166 [TBL] [Abstract][Full Text] [Related]
34. Prognostic performance of multiple biomarkers in patients with non-ST-segment elevation acute coronary syndrome: analysis from the MERLIN-TIMI 36 trial (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Elevation Acute Coronary Syndromes-Thrombolysis In Myocardial Infarction 36). O'Malley RG; Bonaca MP; Scirica BM; Murphy SA; Jarolim P; Sabatine MS; Braunwald E; Morrow DA J Am Coll Cardiol; 2014 Apr; 63(16):1644-53. PubMed ID: 24530676 [TBL] [Abstract][Full Text] [Related]
36. Long-term safety of a novel antianginal agent in patients with severe chronic stable angina: the Ranolazine Open Label Experience (ROLE). Koren MJ; Crager MR; Sweeney M J Am Coll Cardiol; 2007 Mar; 49(10):1027-34. PubMed ID: 17349881 [TBL] [Abstract][Full Text] [Related]